Nomura Tetsuya, Wada Naotoshi, Ota Issei, Tasaka Satoshi, Ono Kenshi, Sakaue Yu, Shoji Keisuke, Keira Natsuya, Tatsumi Tetsuya
Department of Cardiovascular Medicine, Kyoto Chubu Medical Center, 25, Yagi-Ueno, Yagi-cho, Nantan City, Kyoto, 629-0197, Japan.
Cardiovasc Interv Ther. 2023 Jan;38(1):104-112. doi: 10.1007/s12928-022-00885-9. Epub 2022 Aug 17.
Coronary debulking devices are essential in obtaining optimal results in percutaneous coronary intervention (PCI) for severely calcified lesions. However, since the introduction of these devices in Japan, the presence of full-time cardiovascular surgeons in their own facilities has been an essential condition (on-site surgical back-up) as the facility criteria for their use. The criteria were revised in April 2020, making their implementation possible at our hospital. Between May 2020 and January 2022, we administered PCIs using rotational atherectomy (RA) for 33 lesions in 28 patients and orbital atherectomy system (OAS) for 36 lesions in 27 patients. The most preferred strategy in our hospital is OAS via the distal radial approach using a 6Fr Glide sheath or RA via the femoral approach using a 7Fr sheath. The percentages of usable imaging modality as an initial device without lesion modification were 57.1 and 66.7% in the RA and OAS groups, respectively. In the RA procedure, 1.5- and 2.0-mm Rota burrs were more frequently adopted for the initial and second sessions, respectively. In the OAS procedure, the debulking was always initiated at a low speed. Nineteen of the 27 patients underwent additional high-speed debulking. Pre-procedural quantitative coronary angiographic analysis revealed that the minimal lumen diameter was significantly smaller in the RA than in the OAS group. Debulking procedures were successful in all patients excluding two instances of procedure-related complications in the RA group, one of which was coronary perforation safely treated via covered stent deployment without any resulting hemodynamic instability. Our early experience with coronary debulking devices with off-site surgical back-up clearly reveals the safety and feasibility of this procedure in a newcomer facility.
冠状动脉减容装置对于严重钙化病变的经皮冠状动脉介入治疗(PCI)获得最佳效果至关重要。然而,自这些装置在日本引入以来,其所在机构配备全职心血管外科医生一直是使用这些装置的设施标准中的一项基本条件(现场手术支持)。该标准于2020年4月修订,使得我们医院能够实施这些装置的使用。在2020年5月至2022年1月期间,我们对28例患者的33处病变采用旋磨术(RA)进行PCI,对27例患者的36处病变采用轨道旋切系统(OAS)进行PCI。我们医院最常用的策略是通过使用6Fr Glide鞘的桡动脉远端途径进行OAS或通过使用7Fr鞘的股动脉途径进行RA。在未对病变进行修改的情况下,作为初始装置的可用成像方式的百分比在RA组和OAS组中分别为57.1%和66.7%。在RA手术中,初始阶段和第二阶段分别更频繁地采用1.5毫米和2.0毫米的旋磨头。在OAS手术中,减容始终以低速开始。27例患者中有19例接受了额外的高速减容。术前定量冠状动脉造影分析显示,RA组的最小管腔直径明显小于OAS组。除RA组有两例与手术相关的并发症外,所有患者的减容手术均成功,其中一例冠状动脉穿孔通过植入覆膜支架安全治疗,未导致任何血流动力学不稳定。我们在有场外手术支持的情况下使用冠状动脉减容装置的早期经验清楚地表明了该手术在一家新机构中的安全性和可行性。